Latest Pharamcy News

Weight loss pill could mess up mind, banned
Date: 30 Dec. 2008
Mumbai, December 30: The Food and Drug Administration (FDA) has banned the use of weight-loss pill `rimonabant' after research showed that the drug caused serious psychiatric side-effects, including suicidal tendencies among users. About 12 generic companies in India manufacture the anti-obesity drug, which had a tiny, Rs 13-crore market. Read More»

Pharmacies Fight Tough Battle on Generic Prices
Date: 22 Dec. 2008
Retail pharmacies are waging what some consider a generic-drug price war that is threatening margins in a typically high-profit area and reflects the intense competition that drug-store chains face in attracting and keeping customers. Read More»

Drugmakers Could Lose Their Greatest Weapon
Date: 11 Dec. 2008
Pharmaceutical companies are so worried about losing their biggest weapon to increase sales -- direct-to-consumer (DTC) advertisements -- that the industry trade group made a preemptive strike yesterday. Read More»

Lilly to post 2008 loss on ImClone costs
Date: 11 Dec. 2008
NEW YORK (AP) - Eli Lilly & Co. said Thursday hefty costs related to its $6.5 billion acquisition of ImClone will force the drugmaker to post a loss for 2008 and significantly lower earnings for 2009. Read More»

Police Raid Alleged Prescription Pill Lab
Date: 1 Nov. 2008
The Manitowoc County Drug Unit busted a major international drug operation in the Village of Reedsville. Read More»

Snyders Launches Snyders Prescription Savings Club
Date: 19 Oct. 2008
Snyder's Drug Stores launched the Snyder's Prescription Savings Club in Albert Lea and Mankato this weekend Read More»

FTC Busts Major Spam Operation
Date: 15 Oct. 2008
A U.S. district court this week ordered the owners of a major spam operation to shut down their operations immediately. Read More »

The Problem With Medicine Trade Marks
Date: 14 Oct. 2008
The Problem With Medicine Trade Marks Read More »

How drug companies try to get inside your head
Date: 04 Oct. 2008
Unless you are a doctor or a pharmacist, the terms methylphenidate and sildenafil probably don't mean much to you. It is a fair bet that fluoxetine, oseltamivir and trastuzumab will also draw a blank. Yet these tongue- twisting generic names are staples of the health pages. You have read dozens of stories about them. Read More»

Home | Contact Us | Policy Policy